CEO and CFO Roundtables World of Incentives: Non-Equity: What’s Your Plan? | Part Two
This two-part Executive Series Roundtable will discuss compensation package design issues: industry veterans will share their experience with both equity and non-equity components, they try to answer the single most important question: how do you design an incentive program that helps retain top talent?
Non-Equity: What’s Your Plan? | Part Two
With the economy in recession, cash is king. Non-equity incentive compensation can represent a large part of pay for some executives. Discuss with experienced CEOs and industry experts:
- What tools are tried and true: What are the tools of the future?
- How do non-biotech companies design their incentive plans?
- How do you sell non-equity incentive plans to employees?
Partner, Hogan Lovells US LLP
Former Chairman and CEO of XOMA
Mary Haak-Frendscho, PhD
President and Chief Scientific Officer, Takeda San Francisco (TSF)
Igor Gonda, PhD
President and Chief Executive Officer, Aradigm
Diana M. Petty, SPHR
VP Human Resources & Administration, Metabolex, Inc.
Thomas J. Schall, Ph.D.
President and CEO, ChemoCentryx, Inc.
Senior Vice President and CFO, OncoMed Pharmaceuticals Inc.
National Practice Leader, Compensation, Barney & Barney LLC
|What:||CEO and CFO Roundtables
World of Incentives: Non-Equity: What’s Your Plan? | Part Two
|When:||October 11, 2011
|Where:||OncoMed Pharmaceuticals, Inc.
800 Chesapeake Dr.
Redwood City, CA 94063-4748
|Attire:||Business attire suggested|
|Attendance:||Open to C-Suite Executives of Life Sciences Companies Only.|
|Cost:||BayBio Members – FREE
Non-Members – $75.00